Fluorescence Guided Surgery Systems Market

Category : Healthcare & Life Sciences Reports | Delivery Format : PDF,PPT | Publisher: Reports and Insights | Pages : 326

To learn more about this report, request a free sample copy

Fluorescence Guided Surgery Systems Market Overview

The report is titled ‘Fluorescence Guided Surgery Systems Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the fluorescence guided surgery systems market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The fluorescence guided surgery systems market is expected to grow at a significant rate in the near future.

The global fluorescence guided surgery systems market is estimated to reach at a value of US$ xx Mn by the end of 2020 and expected to reach at a value of US$ xx Mn by 2028 with a significant CAGR of xx%

Fluorescence Guided Surgery Systems Introduction

Fluorescence guided surgery or FGS can be understood as an intraoperative medical approach which holds the role to produce a real-time fluorescence image of the surgical section and steer the surgical method. In comparison to the traditional imaging methods such as MRI and CT, fluorescence guided surgery systems have the capability to offer real-time imaging during surgery, and it is much low-priced and much simpler to operate.

Fluorescence Guided Surgery Systems Market Dynamics

One of the major factors that is primarily driving the growth of the global fluorescence-guided surgery systems market is the rising number of surgical processes carried out all across the globe owing to the increasing prevalence of target diseases. Having said that, the long-drawn-out authorization procedures are likely to hinder the growth of the global fluorescence guided surgery systems market. In addition to that, in the past few years, there has been an outbreak of interest and intrigue in fluorescence-guided surgery, which has paved its way to a persistent demand for new commercially prepared and authorized fluorescence imaging devices. Therefore, the global fluorescence guided surgery systems market is projected to rise significantly in the coming years.

Fluorescence Guided Surgery Systems Market Segmentation

The global fluorescence guided surgery systems market is segmented on the basis of type, application, and region.

By Type

SPY system

PDE system

VS3 iridium system

Others

By Application

Head and neck cancer

Breast cancer

Non-small-cell lung cancer

Colorectal cancer

Bladder cancer

Prostate cancer

Others

By Region

North America

Latin America

Europe

Africa

Middle East

Asia Pacific

Fluorescence Guided Surgery Systems Market Key Players

The key participating players of the global fluorescence guided surgery systems market include Stryker, Hamamatsu Photonics K.K., Quest Medical Imaging, Medtronic, Curadel, LLC., LI-COR Biosciences, PerkinElmer, SurgiMab, OnLine Surgical, Fluoptics, among others.

R&I Overview on Fluorescence Guided Surgery Systems Market Report

The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.

A research report on the Fluorescence Guided Surgery Systems market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

New product designs and launches

Current product compliance

Reimbursement

Concerns for use of Fluorescence Guided Surgery Systems

Advantages of Fluorescence Guided Surgery Systems

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to make informed decisions.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment where one/two manufacturer(s) dominates the market, it’s product sales, previous growth rates and market expansion plans are considered to generate market share in the global market.


To learn more about this report, request a free sample copy


1.    Global Fluorescence Guided Surgery Systems Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Fluorescence Guided Surgery Systems Market Overview

2.1.    Introduction

2.1.1.    Introduction

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Fluorescence Guided Surgery Systems Market Snapshot

2.4.    Global Fluorescence Guided Surgery Systems Market Size And Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast And Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Fluorescence Guided Surgery Systems Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Porter’s Five Forces Model

2.7.    SWOT Analysis

2.8.    PEST Analysis

2.9.    Demand Analysis

2.9.1.    By Application

2.9.2.    By Type Industries

2.9.3.    By Region

2.10.    Pricing Analysis

2.10.1.    Regional Pricing Analysis By Product

2.10.2.    Pricing Break-up

2.10.3.    Manufacturer Level Pricing

2.10.4.    Distributor Level Pricing

2.10.5.    Global Average Pricing Analysis Benchmark

2.10.6.    Pricing Analysis by Competition

2.11.    Cross Section Analysis 

2.11.1.    Cross Analysis of Type Industries W.R.T Application

3.    Fluorescence Guided Surgery Systems Assessment and Analysis

3.1.    Fluorescence Guided Surgery Systems Impact Analysis 

3.2.    Actions to encourage use of Fluorescence Guided Surgery Systems

3.3.    Fluorescence Guided Surgery Systems Promotional Strategy Recommendation

3.4.    Potential Analysis

4.    Covid-19 Impact on Fluorescence Guided Surgery Systems Market

4.1.    Impact Analysis of Covid-19 on the global Fluorescence Guided Surgery Systems market

4.2.    Effect On Value Chain

4.3.    Business Impact W.R.T Revenue 

4.4.    Volatility In Price 

4.5.    Effect On The Overall Trade 

4.6.    Market Impact Analysis In 2020 (Quarter Wise)

5.    Global Fluorescence Guided Surgery Systems Market, By Type

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Type

5.1.2.    BPS Analysis, By Type

5.2.    Market Revenue (US$Mn) and Forecast, By Type

5.2.1.    SPY System

5.2.2.    PDE System

5.2.3.    VS3 Iridium System

5.2.4.    Others 

5.3.    Global Fluorescence Guided Surgery Systems Market Attractiveness Index, By Type

6.    Global Fluorescence Guided Surgery Systems Market, By Application

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Application

6.1.2.    BPS Analysis, By Application

6.2.    Market Revenue (US$Mn) and Forecast, By Application

6.2.1.    Head and Neck Cancer

6.2.2.    Breast Cancer

6.2.3.    Non-small-cell Lung Cancer

6.2.4.    Colorectal Cancer

6.2.5.    Bladder Cancer

6.2.6.    Prostate Cancer

6.2.7.    Others

6.3.    Global Fluorescence Guided Surgery Systems Market Attractiveness Index, By Application

7.    Global Fluorescence Guided Surgery Systems Market, By Region

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Region

7.1.2.    BPS Analysis, By Region

7.2.    Market Revenue (US$Mn) and Forecast, By Region

7.2.1.    North America

7.2.2.    Latin America

7.2.3.    Europe

7.2.4.    Asia Pacific

7.2.5.    Middle East 

7.2.6.    Africa

7.3.    Global Fluorescence Guided Surgery Systems Market Attractiveness Index, By Region

8.    North America Fluorescence Guided Surgery Systems Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market Revenue (US$Mn) and Forecast, By Country

8.2.1.    U.S. Fluorescence Guided Surgery Systems Market

8.2.1.1.    Revenue (US$ Mn) & Forecast, By Type

8.2.1.2.    Revenue (US$ Mn) & Forecast, By Application

8.2.2.    Canada Fluorescence Guided Surgery Systems Market

8.2.2.1.    Revenue (US$ Mn) & Forecast, By Type

8.2.2.2.    Revenue (US$ Mn) & Forecast, By Application

8.3.    North America Fluorescence Guided Surgery Systems Market, By Type

8.3.1.    SPY System

8.3.2.    PDE System

8.3.3.    VS3 Iridium System

8.3.4.    Others 

8.4.    North America Fluorescence Guided Surgery Systems Market, By Application

8.4.1.    Head and Neck Cancer

8.4.2.    Breast Cancer

8.4.3.    Non-small-cell Lung Cancer

8.4.4.    Colorectal Cancer

8.4.5.    Bladder Cancer

8.4.6.    Prostate Cancer

8.4.7.    Others

8.5.    North America Fluorescence Guided Surgery Systems Market Attractiveness Index

8.5.1.    By Country

8.5.2.    By Type

8.5.3.    By Application

9.    Latin America Fluorescence Guided Surgery Systems Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    Brazil Fluorescence Guided Surgery Systems Market

9.2.1.1.    Revenue (US$ Mn) & Forecast, By Type

9.2.1.2.    Revenue (US$ Mn) & Forecast, By Application

9.2.2.    Mexico Fluorescence Guided Surgery Systems Market

9.2.2.1.    Revenue (US$ Mn) & Forecast, By Type

9.2.2.2.    Revenue (US$ Mn) & Forecast, By Application

9.2.3.    Rest Of Latin America Fluorescence Guided Surgery Systems Market

9.2.3.1.    Revenue (US$ Mn) & Forecast, By Type

9.2.3.2.    Revenue (US$ Mn) & Forecast, By Application

9.3.    Latin America Fluorescence Guided Surgery Systems Market, By Type

9.3.1.    SPY System

9.3.2.    PDE System

9.3.3.    VS3 Iridium System

9.3.4.    Others 

9.4.    Latin America Fluorescence Guided Surgery Systems Market, By Application

9.4.1.    Head and Neck Cancer

9.4.2.    Breast Cancer

9.4.3.    Non-small-cell Lung Cancer

9.4.4.    Colorectal Cancer

9.4.5.    Bladder Cancer

9.4.6.    Prostate Cancer

9.4.7.    Others

9.5.    Latin America Fluorescence Guided Surgery Systems Market Attractiveness Index

9.5.1.    By Country

9.5.2.    By Type

9.5.3.    By Application

10.    Europe Fluorescence Guided Surgery Systems Market Analysis and Forecast, 2020–2028

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    U.K. Fluorescence Guided Surgery Systems Market

10.2.1.1.    Revenue (US$ Mn) & Forecast, By Type

10.2.1.2.    Revenue (US$ Mn) & Forecast, By Application

10.2.2.    Germany Fluorescence Guided Surgery Systems Market

10.2.2.1.    Revenue (US$ Mn) & Forecast, By Type

10.2.2.2.    Revenue (US$ Mn) & Forecast, By Application

10.2.3.    Italy Fluorescence Guided Surgery Systems Market

10.2.3.1.    Revenue (US$ Mn) & Forecast, By Type

10.2.3.2.    Revenue (US$ Mn) & Forecast, By Application

10.2.4.    France Fluorescence Guided Surgery Systems Market

10.2.4.1.    Revenue (US$ Mn) & Forecast, By Type

10.2.4.2.    Revenue (US$ Mn) & Forecast, By Application

10.2.5.    Spain Fluorescence Guided Surgery Systems Market

10.2.5.1.    Revenue (US$ Mn) & Forecast, By Type

10.2.5.2.    Revenue (US$ Mn) & Forecast, By Application

10.2.6.    Russia Fluorescence Guided Surgery Systems Market

10.2.6.1.    Revenue (US$ Mn) & Forecast, By Type

10.2.6.2.    Revenue (US$ Mn) & Forecast, By Application

10.2.7.    Poland Fluorescence Guided Surgery Systems Market

10.2.7.1.    Revenue (US$ Mn) & Forecast, By Type

10.2.7.2.    Revenue (US$ Mn) & Forecast, By Application

10.2.8.    NORDIC Fluorescence Guided Surgery Systems Market

10.2.8.1.    Revenue (US$ Mn) & Forecast, By Type

10.2.8.2.    Revenue (US$ Mn) & Forecast, By Application

10.2.9.    BENELUX Fluorescence Guided Surgery Systems Market

10.2.9.1.    Revenue (US$ Mn) & Forecast, By Type

10.2.9.2.    Revenue (US$ Mn) & Forecast, By Application

10.2.10.    Rest of Europe Fluorescence Guided Surgery Systems Market

10.2.10.1.    Revenue (US$ Mn) & Forecast, By Type

10.2.10.2.    Revenue (US$ Mn) & Forecast, By Application

10.3.    Europe Fluorescence Guided Surgery Systems Market, By Type

10.3.1.    SPY System

10.3.2.    PDE System

10.3.3.    VS3 Iridium System

10.3.4.    Others 

10.4.    Europe Fluorescence Guided Surgery Systems Market, By Application

10.4.1.    Head and Neck Cancer

10.4.2.    Breast Cancer

10.4.3.    Non-small-cell Lung Cancer

10.4.4.    Colorectal Cancer

10.4.5.    Bladder Cancer

10.4.6.    Prostate Cancer

10.4.7.    Others

10.5.    Europe Fluorescence Guided Surgery Systems Market Attractiveness Index

10.5.1.    By Country

10.5.2.    By Type

10.5.3.    By Application

11.    Asia Pacific Fluorescence Guided Surgery Systems Market Analysis and Forecast, 2020–2028

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    China Fluorescence Guided Surgery Systems Market

11.2.1.1.    Revenue (US$ Mn) & Forecast, By Type

11.2.1.2.    Revenue (US$ Mn) & Forecast, By Application 

11.2.2.    India Fluorescence Guided Surgery Systems Market

11.2.2.1.    Revenue (US$ Mn) & Forecast, By Type

11.2.2.2.    Revenue (US$ Mn) & Forecast, By Application

11.2.3.    Japan Fluorescence Guided Surgery Systems Market

11.2.3.1.    Revenue (US$ Mn) & Forecast, By Type

11.2.3.2.    Revenue (US$ Mn) & Forecast, By Application

11.2.4.    Australia and New Zealand Fluorescence Guided Surgery Systems Market

11.2.4.1.    Revenue (US$ Mn) & Forecast, By Type

11.2.4.2.    Revenue (US$ Mn) & Forecast, By Application

11.2.5.    South Korea Fluorescence Guided Surgery Systems Market

11.2.5.1.    Revenue (US$ Mn) & Forecast, By Type

11.2.5.2.    Revenue (US$ Mn) & Forecast, By Application

11.2.6.    Rest of Asia Pacific Fluorescence Guided Surgery Systems Market

11.2.6.1.    Revenue (US$ Mn) & Forecast, By Type

11.2.6.2.    Revenue (US$ Mn) & Forecast, By Application

11.3.    Asia Pacific Fluorescence Guided Surgery Systems Market, By Type

11.3.1.    SPY System

11.3.2.    PDE System

11.3.3.    VS3 Iridium System

11.3.4.    Others 

11.4.    Asia Pacific Fluorescence Guided Surgery Systems Market, By Application

11.4.1.    Head and Neck Cancer

11.4.2.    Breast Cancer

11.4.3.    Non-small-cell Lung Cancer

11.4.4.    Colorectal Cancer

11.4.5.    Bladder Cancer

11.4.6.    Prostate Cancer

11.4.7.    Others

11.5.    Asia Pacific Fluorescence Guided Surgery Systems Market Attractiveness Index

11.5.1.    By Country

11.5.2.    By Type

11.5.3.    By Application

12.    Middle East Fluorescence Guided Surgery Systems Market Analysis and Forecast, 2020–2028

12.1.    Introduction

12.1.1.    Annual Growth Rate Comparison, By Country

12.1.2.    BPS Analysis, By Country

12.2.    Market (US$Mn) Forecast, By Country

12.2.1.    GCC Countries Fluorescence Guided Surgery Systems Market

12.2.1.1.    Revenue (US$ Mn) & Forecast, By Type

12.2.1.2.    Revenue (US$ Mn) & Forecast, By Application

12.2.2.    Israel Fluorescence Guided Surgery Systems Market

12.2.2.1.    Revenue (US$ Mn) & Forecast, By Type

12.2.2.2.    Revenue (US$ Mn) & Forecast, By Application

12.2.3.    Rest Of Middle East Fluorescence Guided Surgery Systems Market

12.2.3.1.    Revenue (US$ Mn) & Forecast, By Type

12.2.3.2.    Revenue (US$ Mn) & Forecast, By Application

12.3.    Middle East Fluorescence Guided Surgery Systems Market, By Type

12.3.1.    SPY System

12.3.2.    PDE System

12.3.3.    VS3 Iridium System

12.3.4.    Others

12.4.    Middle East Fluorescence Guided Surgery Systems Market, By Application

12.4.1.    Head and Neck Cancer

12.4.2.    Breast Cancer

12.4.3.    Non-small-cell Lung Cancer

12.4.4.    Colorectal Cancer

12.4.5.    Bladder Cancer

12.4.6.    Prostate Cancer

12.4.7.    Others

12.5.    Middle East Fluorescence Guided Surgery Systems Market Attractiveness Index

12.5.1.    By Country

12.5.2.    By Type

12.5.3.    By Application

13.    Africa Fluorescence Guided Surgery Systems Market Analysis and Forecast, 2020–2028

13.1.    Introduction

13.1.1.    Annual Growth Rate Comparison, By Country

13.1.2.    BPS Analysis, By Country

13.2.    Market (US$Mn) Forecast, By Country

13.2.1.    South Africa Countries Fluorescence Guided Surgery Systems Market

13.2.2.    Egypt Fluorescence Guided Surgery Systems Market

13.2.2.1.    Revenue (US$ Mn) & Forecast, By Type

13.2.2.2.    Revenue (US$ Mn) & Forecast, By Application

13.2.3.    North Africa Fluorescence Guided Surgery Systems Market

13.2.3.1.    Revenue (US$ Mn) & Forecast, By Type

13.2.3.2.    Revenue (US$ Mn) & Forecast, By Application

13.2.4.    Rest of Africa Fluorescence Guided Surgery Systems Market

13.2.4.1.    Revenue (US$ Mn) & Forecast, By Type

13.2.4.2.    Revenue (US$ Mn) & Forecast, By Application

13.3.    Africa Fluorescence Guided Surgery Systems Market, By Type

13.3.1.    SPY System

13.3.2.    PDE System

13.3.3.    VS3 Iridium System

13.3.4.    Others 

13.4.    Africa Fluorescence Guided Surgery Systems Market, By Application

13.4.1.    Head and Neck Cancer

13.4.2.    Breast Cancer

13.4.3.    Non-small-cell Lung Cancer

13.4.4.    Colorectal Cancer

13.4.5.    Bladder Cancer

13.4.6.    Prostate Cancer

13.4.7.    Others

13.5.    Africa Fluorescence Guided Surgery Systems Market Attractiveness Index

13.5.1.    By Country

13.5.2.    By Type

13.5.3.    By Application

14.    Competitive Landscape

14.1.    Competition Dashboard

14.2.    Company Share Analysis

14.2.1.    Market Analysis by Tier of Companies

14.2.2.    Market Share Analysis of Top Players

14.2.3.    Market Presence Analysis

14.2.4.    Regional Footprint of Players

14.2.5.    Product Footprint by Players

14.2.6.    Channel Footprint by Players

14.3.    Company Profiles

14.3.1.    Stryker

14.3.1.1.    Company Overview

14.3.1.2.    Financial Overview

14.3.1.3.    Key Developments

14.3.1.4.    SWOT Analysis

14.3.1.5.    Strategies

14.3.1.6.    Product Analysis

14.3.2.    Hamamatsu Photonics K.K.

14.3.3.    Quest Medical Imaging

14.3.4.    Medtronic

14.3.5.    Curadel, LLC.

14.3.6.    LI-COR Biosciences

14.3.7.    PerkinElmer

14.3.8.    SurgiMab,OnLume Surgical

14.3.9.    Fluoptics

15.    Acronyms

Select License Type

Frequently Asked Questions

Fluorescence guided surgery or FGS can be understood as an intraoperative medical approach which holds the role to produce a real-time fluorescence image of the surgical section and steer the surgical method. In comparison to the traditional imaging methods such as MRI and CT, fluorescence guided surgery systems have the capability to offer real-time imaging during surgery, and it is much low-priced and much simpler to operate

The rising number of surgical processes carried out all across the globe owing to the increasing prevalence of target diseases is one of the major factor driving the growth of market

The global fluorescence guided surgery systems market is segmented on the basis of type, application, and region.

The key participating players of the global fluorescence guided surgery systems market include Stryker, Hamamatsu Photonics K.K., Quest Medical Imaging, Medtronic, Curadel, LLC., LI-COR Biosciences, PerkinElmer, SurgiMab, OnLine Surgical, Fluoptics, among others